A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Insulin may have protective roles in vascular cells, but its vascular effects in patients with atherosclerosis are unknown. Dipeptidyl peptidase 4 (DPP4) inhibitors are a class of insulin-sensitising agents that may regulate vascular responses to insulin in humans. We attempted to determine the direct vascular effects of insulin in humans with atherosclerosis, and explore the effect of DPP4 inhibition on vascular insulin signalling.doi:10.1136/heartjnl-2018-bcs.126 fatcat:trpq23tdczb67hivi2p77h7ysu